| 翻訳と辞書 |
| Dr. Mark J. Poznansky ： ウィキペディア英語版 |
Mark J. Poznansky
Mark J. Poznansky, O.Ont, C.M. (born April 5, 1946) is a research scientist and science administrator. He is the President and CEO of the Ontario Genomics Institute (OGI) and was previously Chair of the Board of OGI, and the founder of G2G Consulting Inc. He is a member of the Order of Canada, a member of the Order of Ontario and the former CEO, President and former Scientific Director of Robarts Research Institute.
==Education and early career history==
Born in Montreal, Poznansky was educated at McGill University, receiving his PhD in Physiology in 1970. Poznansky completed his postdoctoral training in Biophysics at Harvard Medical School in 1972,〔(Ontario Genomic Institute Board Member page that presents Dr. Mark Poznansky's biography, including a discussion of his education at McGill and postdoctorate training at Harvard. )〕 where he held the position of Lecturer in Biophysics until 1976. He also served as Charge de Recherche at the Collège de France in Paris from 1973 to 1974.
Poznansky returned to Canada in 1976, taking a position as Associate Professor of Physiology at the University of Alberta in Edmonton.〔(Press release on Dr. Mark Poznansky by Thunder Bay Regional Research Institute that presents biographical information including a discussion of his stints at University of Alberta and Harvard. )〕 Over the next 18 years, he rose to the rank of Professor and his laboratory developed an international reputation both the areas of cholesterol 〔(Transbilayer movement of cholesterol in dipalmitoyllecithin−cholesterol vesicles. )〕 and membrane biophysics 〔Regulation of human red cell volume by linked cation fluxes published in Journal of Membrane Biology, Volume 10, Number 1/December, 1972, Page 259-266〕 as well as enzyme replacement therapy 〔Enzyme-Albumin Polymers: New Approaches to the Use of Enzymes in Medicine published in Artificial Cells, Blood Substitutes, and Biotechnology, Volume 15, Issue 4 January 1987, Pages 751 - 774〕 and the development of novel approaches to drug delivery.〔(A modified tetramethylbenzidine method for measuring lipid hydroperoxides. )〕 In 1984, Poznansky moved on to become the Associate Dean of Medicine at the University of Alberta in Edmonton, a position he held for 9 years.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Mark J. Poznansky」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|